drugset / Trial / NCT05410626
The Study of Efficacy and Safety of Generic Methylphenidate Prolong-released Comparison With Original
RandomizedCrossoverDouble-blindTreatment
Summary
This study is a cross-over trial, design to determine the efficacy and safety of generic and original prolong-release methylphenidate (PR-MPH) in children with ADHD who had received immediate-release methylphenidate treatment
Timeline
- Start
- 2022-06-01
- Primary completion
- 2022-08-31
- Completion
- 2022-08-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Methylphenidate | Small molecule | 18 mg | — |
| Subject | Methylphenidate | Small molecule | 36 mg | — |